-Cardiacspecific overexpression of nerve growth factor (NGF), a neurotrophin, leads to sympathetic hyperinnervation of heart. As a consequence, adverse functional changes that occur after chronically enhanced sympathoadrenergic stimulation of heart might develop in this model. However, NGF also facilitates synaptic transmission and norepinephrine uptake, effects that would be expected to restrain such deleterious outcomes. To test this, we examined 5-to 6-mo-old transgenic (TG) mice that overexpress NGF in heart and their wild-type (WT) littermates using echocardiography, invasive catheterization, histology, and catecholamine assays. In TG mice, hypertrophy of the right ventricle was evident (ϩ67%), but the left ventricle was only mildly affected (ϩ17%). Left ventricular (LV) fractional shortening and fractional area change values as indicated by echocardiography were similar between the two groups. Catheterization experiments revealed that LV ϮdP/dt values were comparable between TG and WT mice and responded similarly upon isoproterenol stimulation, which indicates lack of ␤-adrenergic receptor dysfunction. Although norepinephrine levels in TG LV tissue were approximately twofold those of WT tissue, TG plasma levels of the neuronal norepinephrine metabolite dihydroxyphenyglycol were fivefold those of WT plasma. A greater neuronal uptake activity was also observed in TG LV tissue. In conclusion, overexpression of NGF in heart leads to sympathetic hyperinnervation that is not associated with detrimental effects on LV performance and is likely due to concomitantly enhanced norepinephrine neuronal uptake. echocardiography; myocardial contraction; catecholamine; transgenic; nerve growth factor CARDIAC SYMPATHETIC TONE IS enhanced under conditions of heart failure (13, 14). Prolonged and excessive sympathoadrenergic stimulation of heart leads to adverse biological consequences such as myocardial cell death, hypertrophy, and fibrosis (30). In the setting of heart failure, preferential activation of cardiac sympathetic nerves contributes to norepinephrine (NE) spillover from heart to plasma at 5-50 times the normal rate depending on the severity of the disease (14). Such enhanced NE spillover is due to both an increase in nerve firing rate and an attenuation in NE reuptake (14). Elevated plasma NE levels bear prognostic value (22) and have been linked to hemodynamic abnormalities and mortality in patients (6, 26). Within this context, the therapeutic efficacy of ␤-blockers in patients with heart failure has been well documented (10, 17).
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The detrimental effects of enhanced adrenergic stimulation have been confirmed by recent studies on transgenic (TG) mice, which show that cardiac restricted overexpression of ␤ 1 -, ␤ 2 -, and ␣-adrenergic receptors (ARs) and G s ␣ protein all result in cardiomyopathy and premature death (9, 12, 21, 25, 28) . Cardiac targeted overexpression of nerve growth factor (NGF), a neurotrophin that is essential for sympathetic neuronal differentiation, maturation, and survival (20, 27, 37) , leads to sympathetic hyperinnervation of heart (18) . It has been postulated (1, 18, 19 ) that this mouse model would also lead to heart failure or a cardiac dysfunction phenotype, a possibility that has not been investigated. However, although NGF plays a central role in promoting growth of sympathetic nerve dendrites, it is also important for synaptic function. Notably, once it is released, the majority of NE is cleared from the synaptic cleft via the NE transporter (11) . NGF has been shown to increase uptake-1 activity in sympathetic nerves (39) and chromaffin cells (40) and to facilitate synaptic transmission in cultures of sympathetic neurons and cardiac myocytes (29) . Hence, we hypothesize that although cardiac NGF overexpression leads to sympathetic hyperinnervation (18) , it also promotes synaptic clearance of NE, and as such, adverse consequences after a prolonged adrenergic overstimulation, which is seen in failing heart, would not occur in this model. We have addressed this question by investigating heart morphology and in vivo function in mice with cardiac-specific overexpression of NGF.
MATERIALS AND METHODS
Animals. These studies were approved by the local Animal Ethics Committee and conformed to guidelines set out in the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes. Mice of either gender were studied at 5-6 mo of age unless otherwise specified. TG mice (line 4, 8 -10 transgene copies) with NGF overexpression driven by a cardiac-specific ␣-myosin heavy-chain promoter (18) were studied in parallel to non-TG wild-type (WT) littermates. The colony was maintained in a DBA2J background.
Echocardiography. In vivo heart function and chamber dimensions were assessed with two-dimensional targeted M-mode echocardiography while mice were under light anesthesia (6 mg/100 g ketamine, 1.5 mg/100 g xylazine, and 0.045 mg/100 g atropine ip) using a Hewlett-Packard Sonos 5500 ultrasonograph with a 15-MHz linear array as described previously (38) . Measurements of left ventricular (LV) end-diastolic dimension (EDD), end-systolic dimension (ESD), and wall thickness at end diastole were made from captured freeze frames of M-mode images by applying the leading-edge convention of the American Society of Echocardiography. Right ventricular (RV) and left atrial dimensions were measured from two-dimensional (2-D) images. Fractional shortening was calculated as [(EDD Ϫ ESD)/EDD] ϫ 100%.
To ensure that the LV functional comparison between WT and TG mice was not biased by a particular anesthetic, echocardiography was performed on a small cohort of animals using Avertin anesthesia (2.5 mg/10 g ip). Response to maximal ␤-agonist stimulation was also assessed in these mice 2 min after isoproterenol injection (3 g/kg ip).
Micromanometry. Blood pressure and LV contractile parameters were determined in closed-chest anesthetized mice (6 mg/100 g pentobarbitone and 0.06 mg/100 g atropine ip) using a 1.4-Fr Millar Mikro-Tip catheter as previously described (7) . Values for LV ϮdP/dt and heart rate (HR) were assessed at baseline and after intravenous infusion of isoproterenol (0.1-6 ng/mouse). In addition, end-diastolic pressure and the time constant of LV relaxation () were assessed at baseline. We calculated using the conventional exponential method and the logistic method (31) . Curves were fitted to the pressure trace from the time of maximal ϪdP/dt to a level 5 mmHg above the end-diastolic pressure of the next contraction; the correlation coefficient of each curve fit was Ն0.998.
Isolated atrial experiments. To further investigate chronotropic properties, WT and TG mouse atria were isolated from ϳ3-mo-old mice and placed into an organ bath maintained at 37°C as previously described (5) . The right and left atria were connected to an isometric force transducer using silk sutures. HR values were calculated from spontaneous beating rates. The preparation was left to equilibrate (for 45-90 min) until the HR did not change by Ͼ10 beats/min for 20 min. Cumulative NE dose-response curves (10 Ϫ8 to 10 Ϫ4 mol/l) were subsequently obtained.
Autopsy and histology. Atria, ventricles, and lungs were lightly blotted and weighed. Heart tissue and plasma were snap-frozen in liquid nitrogen and stored at Ϫ80°C. Some whole hearts were fixed in 4% paraformaldehyde in phosphate-buffered solution (pH 7.4) for 12-18 h, subsequently processed, and fixed in paraffin blocks, and serial longitudinal 6-m sections were cut and stained with either hematoxylin and eosin or 0.1% picrosirius red (Polysciences).
Catecholamine determination. Atrial and ventricular tissues were accurately weighed before being homogenized on ice in 0.4 ml of 0.4 mol/l perchloric acid that contained 0.01% EDTA. The homogenate was then rapidly centrifuged. Catecholamines were extracted from the perchloric acid supernatant and also from thawed plasma samples via alumina adsorption and were separated by high-performance liquid chromatography. Amounts were quantified by electrochemical detection according to previously described methods (24, 32) . NE uptake. NE uptake studies were performed according to the methods of Percy et al. (35) with modifications. LV tissue strips (ϳ20 mg) were obtained from 6-mo-old WT and TG mice and were preincubated for ϳ30 min at 37°C in Krebs-Henseleit solution (4 ml/well) that contained (in mM) 148 Na ϩ , 4.0 K ϩ , 1.8 Ca 2ϩ , 1.05 Mg 2ϩ , 25 HCO 3 Ϫ , 0.5 PO 4 3Ϫ , 11 glucose, 0.027 EDTA, 0.4 ascorbic acid, 0.01 Ro 41-1049 (monoamine oxidase A inhibitor; Sigma RBI), 0.01 Ro 41-0960 (catechol-O-methyltransferase; Sigma RBI), and 0.03 corticosterone (an uptake-2 inhibitor; Sigma); some wells also contained 0.003 desipramine (an uptake-1 inhibitor; Sigma). This was followed by a 1-h uptake incubation with [ 3 H]NE (0.25 Ci/ml). We obtained [7- 3 H]NE (16 Ci/mmol) from NEN. After incubation, the LV strips were blotted, weighed, and placed in 3% trichloroacetic acid overnight before radioactivity was measured in scintillation fluid using a beta counter. In the presence of desipramine, [ 3 H]NE uptake was reduced by ϳ70%. Levels of LV uptake-1 [in disintegrations/min (dpm)/mg] were estimated from the differences between [ 3 H]NE contents in the absence and presence of desipramine.
Statistics.
Results are presented as means Ϯ SE. Unless otherwise specified, comparisons between TG and WT mouse data were made using unpaired Student's t-test, and dose-response curves were assessed using two-way repeated-measures ANOVA. Differences were considered significant at P Ͻ 0.05. When the ANOVA indicated a statistically significant difference, the Student-Newman-Keuls test was subsequently employed as a post hoc test.
RESULTS
In vivo heart structure and function. Echocardiography revealed striking structural differences between TG and WT mouse hearts in vivo predominately in atria and right ventricles. Two-dimensional longitudinal (long-axis) images of hearts showed enlarged left atria and right ventricles in TG animals (Fig. 1A) . The enlarged right ventricles were also clearly evident from the cross-sectional (short-axis) heart views ( Fig. 1B) . Specifically, RV EDD and the left atrium-toaorta diameter ratios were significantly increased in TG mice (Table 1) . Conversely, LV dimensions were unchanged by overexpression of NGF ( Fig. 1 and Table 1 ).
In vivo RV and LV performance levels were not markedly different between TG and WT mice. Fractional shortening values as assessed from LV M-mode images were similar for the two genotypes (Table 1) . RV fractional shortening values could be estimated from 2-D short-axis loops by measuring RV diameters at end diastole and end systole; these were also found to be similar between groups. Furthermore, fractional area changes, as determined by measuring the ventricular chamber areas at end diastole and end systole, were essentially identical for WT and TG mice for both left and right ventricles (Table 1) . LV function values were also evaluated in a small cohort of animals anesthetized with Avertin (see below).
From catheterization experiments, neither LV end-diastolic pressure (3.9 Ϯ 0.4 vs. 3.2 Ϯ 0.4 mmHg; n ϭ 9 -12 mice) nor (exponential, 14.4 Ϯ 0.9 vs. 12.9 Ϯ 0.9 ms; logistic, 6.5 Ϯ 0.4 vs. 6.2 Ϯ 0.4 ms; n ϭ 8 -10 mice) values were significantly altered between WT and TG mice, respectively. These data imply an absence of diastolic dysfunction in TG mice.
Functional responses to ␤-agonists. Aortic systolic/diastolic pressures were similar between WT (n ϭ 9) and TG (n ϭ 8) mice at 91 Ϯ 5/59 Ϯ 4 vs. 93 Ϯ 5/61 Ϯ 5 mmHg, respectively. The postjunctional ␤-AR-mediated response was assessed in WT and TG mice (see Fig. 2A ). Values for HR, ϩdP/dt, and ϪdP/dt were not significantly different between WT and TG mice under basal conditions. Furthermore, stimulation with isoproterenol revealed similar LV ϮdP/dt dose-response curves for WT and TG animals (Fig. 2 ). There was a blunted HR response in TG mice that might have somewhat underestimated LV ϮdP/dt values, which are rate-dependent parameters, at higher isoproterenol concentrations. Nevertheless, contractility values were similar between groups at the 1-ng isoproterenol dose where HR values were identical for WT and TG mice (Fig. 2A) .
LV function values under basal and maximal isoproterenolstimulated conditions (3 g/kg ip) were also obtained upon echocardiographic examination of mice anesthetized with Avertin (n ϭ 4 mice/group). First, LV fractional shortening values were not significantly different between WT and TG mice, which corroborates findings obtained when ketaminexylazine-atropine anesthesia was used. Second, as observed in catheter experiments, the maximal chronotropic response to isoproterenol was blunted in TG mice (Fig. 2B) .
In vivo basal HR was measured while three anesthetic regimes were used including 1) ketamine, xylazine with atropine ( Table 1) ; 2) pentobarbitone with atropine (Fig. 2A) ; and 3) Avertin (Fig. 2B) . Regardless which anesthetic was used, basal HR values were not significantly different between WT and TG mice. A difference was only observed in the presence of ␤-agonists, with the TG animals showing a blunted response. This was further investigated in vitro using atria isolated from WT and TG hearts (Fig. 2C) . The increase in spontaneous beating rate in response to increasing NE concentrations was attenuated in TG atria.
Autopsy and histological findings. Gross morphological differences between WT and TG mouse hearts were evident at autopsy and corroborated with findings from echocardiography. Specifically, TG hearts were characterized with markedly enlarged atria and right ventricles and had only mild hypertrophy of the left ventricles (degree of enlargement was as follows: right atrium Ͼ left atrium Ͼ right ventricle Ͼ left ventricle; Fig. 3, A, B, and D) . Values for lung mass normalized for body mass were not significantly different between WT and TG mice (5.61 Ϯ 0.29 vs. 5.37 Ϯ 0.23 mg/g), which suggests the absence of pulmonary congestion in TG mice.
Histological examination of TG hearts revealed the presence of substantial fibrosis in atria (as judged by positive picrosirius red staining) with less in right ventricles and only minor Values are means Ϯ SE; n ϭ *10 or †10 or 11 mice. Transgenic mice had nerve growth factor overexpression in heart. 2-D indicates parameters were derived from two-dimensional echocardiography images. LV, left ventricular; RV, right ventricular; ‡P Ͻ 0.05 vs. wild-type. changes in left ventricles (degree of fibrosis was as follows: right atrium Ͼ left atrium Ͼ right ventricle Ͼ left ventricle; Fig. 3, B and C) . The upper part of the septum, which borders with the atria, was also affected. Fibrosis in the right ventricle appeared to be interstitial, whereas a different pattern was evident for the atria and affected septum in that the latter had highly nucleated areas (Fig. 3C) .
The striking effects of TG overexpression on atrial tissue prompted us to look at neonatal hearts. Hearts from 1-day-old TG mice were clearly discernible from their WT littermates, particularly with regard to the appearance of atria (Fig. 3E) , which suggests that the atrial changes largely occurred in utero.
Heart and plasma catecholamine levels and neuronal uptake. The cardiac distribution of NE was inhomogeneous as follows: atria Ͼ right ventricle Ͼ left ventricle in WT hearts (Fig. 4A) . A similar trend was seen in TG hearts except that NE was significantly increased compared with WT counterparts, and higher levels were observed in atria than ventricles (Fig.  4A) . Tissue levels of dihydroxyphenylglycol (DHPG), which is an intraneural NE metabolite, and dihydroxyphenylacetic acid Fig. 2 . Functional responses to ␤-adrenergic agonist. Isoproterenol dose-response curves demonstrate unchanged maximal rates of LV contraction (ϩdP/dt) and relaxation (ϪdP/ dt) in closed-chest cardiac catheterized NGF-overexpressing (TG) mice compared with WT mice (A). Heart rate (HR): isoproterenol dose-response curve was significantly blunted for TG vs. WT mice;
# P Ͻ 0.05 for genotype times dose (two-way repeated-measures ANOVA). An attenuated HR response to maximal isoproterenol stimulation (hatched bars) was also evident in TG mice anesthetized with Avertin for echocardiographic studies (B). Values for basal fractional shortening (open bars) and HR were similar between the groups. *P Ͻ 0.05 compared with respective baseline (paired t-test); n ϭ 4 mice/group. Additional evidence was obtained of blunted HR response in TG animals (C), this time in isolated atrial preparations exposed to increasing concentrations of norepinephrine ([NE]); *P Ͻ 0.05 compared with respective TG value;
# P Ͻ 0.05 for genotype times dose (two-way repeated-measures ANOVA); n, no. of animals is shown. (DOPAC), a dopamine metabolite, were also assessed (Fig. 4 , B and C). TG mouse hearts had increased levels of these metabolites, particularly in the atria.
Plasma catecholamine levels were increased in TG mice (Fig. 4D) . Moreover, plasma levels of DHPG were markedly increased (Fig. 4D) . Because plasma levels of DHPG can serve as a marker of NE uptake (16) , the data suggest that there was greater neuronal uptake and metabolism of NE in TG hearts. Myocardial uptake of [ 3 H]NE was determined using LV muscle strips. LV uptake-1 (desipramine-sensitive)-mediated uptake of [ 3 H]NE was greater in TG than in WT mice (3,532 Ϯ 109; n ϭ 3 vs. 1,698 Ϯ 433 dpm/mg of tissue mass; n ϭ 4 strips, respectively; P Ͻ 0.05). These findings are consistent with the catecholamine data and together imply enhanced NE neuronal uptake in LV myocardium of TG mice.
DISCUSSION
At 6 mo of age, mice that overexpressed NGF in heart showed significant sympathetic hyperinnervation and remarkable changes in atria and right ventricles with substantial hypertrophy and fibrosis. These pathologies might have been expected considering the cardiomyopathic phenotype in TG mice due to overexpression of ␤ 1 -AR (12), ␤ 2 -AR (9, 28), ␣-AR (25), or G s ␣ protein (21) and long-term exposure to NE (3, 30) . However, the NGF TG model differs from other cardiomyopathy models in that the structure and function of the left ventricle was basically normal and a blunted ␤-AR-mediated contractile response, which usually occurs under conditions of enhanced sympathoadrenergic stimulation or cardiac hypertrophy and failure (4, 15) , was not present.
The ␣-myosin heavy-chain promoter used to drive the NGF transgene is transcriptionally active in atria during embryonic development (18, 34) ; ventricular activation of this promoter only occurs after birth (34) . The morphological abnormalities in the TG mice are most dramatic in the atria, and these changes were evident in newborn animals, which indicates an "artificial phenotype" due directly to embryonic activation of the transgene. Earlier studies with this model have shown the presence of ectopic cells in atria and basal portions of heart that were likely derived from neural crest (1, 18) . These cells do not exhibit contractile activity or membrane excitability and appear to be immature Schwann cells and ectomesenchymal-related cells (1) . The large areas of positive picrosirius red staining (which is a marker of collagen) observed in TG mouse atria, at the base of ventricular septum, and in the right ventricle may be due to stimulatory effects of NGF on fibroblasts (33) in addition to the likelihood of NE-induced interstitial fibrosis (3).
Our finding of preserved structure and function of the left ventricle in this model is of interest. Despite the evidence from catecholamine analysis of LV tissue that indicates sympathetic hyperinnervation, the morphological phenotype of the left ventricle is minor relative to the right ventricle and the atria, and LV function values at baseline and, more importantly, under ␤-adrenergic agonist stimulation were comparable to those of WT control mice. We consider this to be the likely "true" phenotype of NGF overexpression in vivo. Conversely, electrophysiological studies on isolated ventricular myocytes from 4-to 8-wk-old TG mice showed reduced peak inward calcium currents upon isoproterenol stimulation compared with WT mice (19) . The same study showed unchanged total density of ␤ 1 -AR, upregulation in ␤ 2 -AR, and uncoupling of ␤-ARs from the adenylyl cyclase signaling pathway in TG mouse hearts (19) . The present findings of intact functional responses to isoproterenol in TG mice in vivo by catheter and by echocardiography strongly indicate intact ␤-AR signaling in the left ventricles of TG mice. Because there is strong evidence that the response to sympathoadrenergic stimulation is largely mediated by ␤ 1 -ARs (2, 8, 38) , these results indicate that enhanced NGF activity leading to sympathetic hyperinnervation is not associated with ␤-AR dysfunction, a finding that Fig. 4 . Catecholamine profile. NE contents of ventricular and atrial tissue from WT and TG mice are shown (A). WT mouse right and left atrial tissues were pooled (A). TG mice had significantly elevated NE levels compared with WT mice. Metabolites of NE and dopamine, dihydroxyphenyglycol (DHPG; B), and dihydroxyphenylacetic acid (DOPAC; C), were also increased in TG heart tissue. Plasma levels of epinephrine (E) and DHPG were elevated in TG mice compared with WT animals (D). *P Ͻ 0.05 compared with respective WT mouse value; # P Ͻ 0.05 compared with left atrium; n, no. of animals.
differs significantly from that seen in diseased hearts. There was, however, a blunted chronotropic response to ␤-AR stimulation. The reason for this finding is not clear but seems intrinsic to the atria (as ex vivo experiments showed an analogous phenomenon) and may be related to histopathological abnormalities in atrial tissue compromising the function of pacemaker cells. Furthermore, it has been suggested (19) that TG mice may be predisposed to cardiac arrhythmias based on the finding of a significantly prolonged duration of action potential repolarization in isolated myocytes. However, functional data obtained from anesthetized TG animals did not reveal any arrhythmias.
Catecholamine excess per se has detrimental effects on heart (3, 30). Furthermore, genetic models of enhanced adrenergic stimulation develop cardiomyopathic phenotypes (9, 12, 21, 25, 28) . The present study is the first to investigate cardiac function in the NGF overexpression model. As stated above, there is no evidence of LV dysfunction even at 6 mo of age; also, the absence of lung congestion eliminates the possibility of any LV pump failure in these mice. Why does sympathetic hyperinnervation in this model not lead to the expected adverse effects on the left ventricle? Such disparity might be explained by the fact that NGF not only increases sympathetic nerve density but also enhances NE uptake (40) . That this may be the case in the present study is supported by the findings in TG mice of increased plasma levels of DHPG and DOPAC, which are the intraneuronal metabolites of NE and dopamine, respectively. Furthermore, uptake-1 in LV tissue from TG mouse hearts was enhanced. Thus although the sympathetic drive to the heart of NGF TG mice is increased, the tonic activation of myocardial ARs is prevented by a concomitantly enhanced clearance of NE from the synaptic gap. These findings are in keeping with our hypothesis that the detrimental effects of an elevated sympathetic drive to the heart could be prevented if they are balanced by an increased uptake that functions as a braking mechanism to timely terminate AR activation.
In conclusion, overexpression of NGF in heart leads to sympathetic hyperinnervation that is not associated with detrimental effects on LV structure and performance and is likely due to a concomitant enhancement of NE neuronal uptake. The observed phenotype of atrial and RV remodeling, hypertrophy, and fibrosis is unlikely due to enhanced cardiac sympathetic activity but is due directly to NGF overexpression during the developmental stage. Reduced expression of NGF has recently been observed in humans and with experimental congestive heart failure and is likely to be NE mediated (23, 36) . Reduced NGF levels provide an explanation for the alterations in morphology as well as function of sympathetic neurons leading to uncontrolled NE spillover in congestive heart failure. We speculate that restoring NGF levels would be helpful in congestive heart failure by enhancing neuronal NE reuptake. Accordingly, conditional TG mouse models with cardiac-targeted overexpression of NGF offer an ideal approach for directly addressing this possibility.
